Models Name |
Cat.No. |
Animal Type |
Disease Area |
Inflammation, transgenic (K14/HPV16 +/-), in mouse (FVB/N)
|
AB56489 |
mouse |
Inflammatory disorders |
Inflammation, zymosan-induced, in mouse (FVB)
|
AB56490 |
mouse |
Inflammatory disorders |
Inflammatory bowel disease, Abcb1a knockout, in mouse (FVB)
|
AB56491 |
mouse |
Inflammatory bowel disease |
Insulin resistance, skeletal muscle conditional transgenic (TFAM)/high-fat diet-induced, in mouse (FVB)
|
AB56492 |
mouse |
Insulin resistance |
Intracerebral hemorrhage, transgenic (GFAP/HMOX1)/collagenase-induced, in mouse (FVB)
|
AB56493 |
mouse |
Intracerebral hemorrhage |
Intrahepatic cholangiocarcinoma, transgenic (NICD), in mouse (FVB/N)
|
AB56494 |
mouse |
Cholangiocarcinoma,intrahepatic |
Intrahepatic cholangiocarcinoma, transgenic (NICD/N-Ras (V12) mutated), in mouse (FVB/N)
|
AB56495 |
mouse |
Cholangiocarcinoma,intrahepatic |
Intrahepatic cholangiocarcinoma, transgenic (NICD/YAP1 (S127A) mutated), in mouse (FVB/N)
|
AB56496 |
mouse |
Cholangiocarcinoma,intrahepatic |
Intrahepatic cholangiocarcinoma, transgenic (NOTCH1/myr-AKT1/S100B/HPGD), in mouse (FVB)
|
AB56497 |
mouse |
Cholangiocarcinoma,intrahepatic |
Intrahepatic cholangiocarcinoma, transgenic (YAP1 (S127A) mutated), in mouse (FVB/N)
|
AB56498 |
mouse |
Cholangiocarcinoma,intrahepatic |